← Leaderboards
David W. Howell
Bondwell Technologies Lp
$2,956,177
Attributed
$4,049,312
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,049,312 · 1
By mechanism
R44$4,049,312 · 1
Top collaborators
- Sarah E Bondos2 shared
- Zivko Nikolov2 shared
Others in their field
Other Emerging Leaders on “Industry”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Lynn Briscoe · Leidos Biomedical Research, Inc.$141,235,417
- Leonard Freedman · Leidos Biomedical Research, Inc.$115,285,092
- John E West · University Of Texas At Austin$94,000,000
Research focus
IndustryLicensingElectrospinningIndustrializationInternationalLeadBindingAdoptionAutoimmune DiseasesGenerationsIndustry PartnerAntibodiesCell Culture TechniquesInterviewChimeric ProteinsChromatographyClinical EfficacyAntibody TherapyCommercializationCostCrosslinkFiberCancer TypeLiterature
Grant awards (4)
A high-efficiency, low-cost, single-use purification technology for therapeutic antibody manufacturing$1,155,951
R44 · FY2025 · GM · contact PI
A high-efficiency, low-cost, single-use purification technology for therapeutic antibody manufacturing$1,253,658
R44 · FY2024 · GM · contact PI
A high-efficiency, low-cost, single-use purification technology for therapeutic antibody manufacturing$820,953
R44 · FY2022 · GM · contact PI
A high-efficiency, low-cost, single-use purification technology for therapeutic antibody manufacturing$818,750
R44 · FY2021 · GM · contact PI